SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | +100.0% | 6,430 | +94.8% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 3,300 | +35.2% | 0.00% | – |
| Q4 2021 | $8,000 | +700.0% | 2,440 | +454.5% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 440 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 440 | +10.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 400 | +300.0% | 0.00% | – |
| Q4 2020 | $1,000 | -83.3% | 100 | -84.6% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 650 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +75.0% | 650 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
| Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
| Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
| ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
| Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
| 683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
| EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
| ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
| Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |